{
  "symbol": "MRK",
  "frequency": "annual",
  "timestamp": "2025-09-19T15:21:35.996569",
  "data": {
    "cik": "310158",
    "data": [
      {
        "accessNumber": "0001628280-25-007732",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2024,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2024-01-01 00:00:00",
        "endDate": "2024-12-31 00:00:00",
        "filedDate": "2025-02-25 00:00:00",
        "acceptedDate": "2025-02-25 16:19:11",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 13242000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 447000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $89 in 2024 and $88 in 2023)",
              "value": 10278000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $4,193 in 2024 and $3,348 in 2023 classified in Other assets - see Note\u00a07)",
              "value": 6109000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 8706000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 38782000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 463000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 307000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 16360000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 18283000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 7984000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 42934000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 19155000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 23779000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21668000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 16370000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 16044000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 117106000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2649000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 4079000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 15694000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 3914000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 2084000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 28420000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 34462000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1387000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 6465000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2024 and 2023",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44704000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 63069000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4945000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 104616000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,049,466,187 shares in 2024 and 1,045,470,249 shares in 2023",
              "value": 58303000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 46313000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 59000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 46372000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 117106000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 64168000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 15193000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10816000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 17938000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 309000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 24000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total costs, expenses and other",
              "value": 44232000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 19936000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 2803000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 17133000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 16000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 17117000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 6.76
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 6.74
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized income (loss) on derivatives, net of reclassifications",
              "value": 266000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -466000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -516000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 216000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income (Loss) Attributable to Merck\u00a0& Co., Inc.",
              "value": 17333000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 17133000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 2395000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 2100000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 39000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "(Income) loss from investments in equity securities, net",
              "value": 14000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charges for certain research and development asset acquisitions",
              "value": 3456000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -1249000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 761000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -510000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 244000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 835000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 182000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -2328000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1023000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -49000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 1416000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 21468000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3372000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 519000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi",
              "unit": "usd",
              "label": "Proceeds from sale of Seagen Inc. common stock",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 377000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Eyebiotech Limited, net of cash acquired",
              "value": 1344000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFour",
              "unit": "usd",
              "label": "Acquisition of Elanco Animal Health Incorporated aqua business",
              "value": 1303000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Harpoon Therapeutics, Inc., net of cash acquired",
              "value": 746000000
            },
            {
              "concept": "mrk_PaymentsToAcquireGlobalRights",
              "unit": "usd",
              "label": "Acquisition of MK-1045 from Curon Pharmaceutical",
              "value": 700000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 127000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -7734000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1290000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 3599000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1306000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 7840000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 177000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -372000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -7032000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -293000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 6409000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-24-006850",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2023,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2023-01-01 00:00:00",
        "endDate": "2023-12-31 00:00:00",
        "filedDate": "2024-02-26 00:00:00",
        "acceptedDate": "2024-02-26 16:06:55",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 6841000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 252000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $88 in 2023 and $72 in 2022)",
              "value": 10349000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $3,348 in 2023 and $2,938 in 2022 classified in Other assets - see Note\u00a08)",
              "value": 6358000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 8368000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 32168000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 252000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 326000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 14966000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 17763000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 8262000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 41317000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 18266000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 23051000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21197000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 18011000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 11996000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 106675000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1372000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3922000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 15766000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2649000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1985000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 25694000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 33683000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 871000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8792000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44509000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 53895000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5161000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 95031000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,045,470,249 shares in 2023 and 1,039,269,638 shares in 2022",
              "value": 57450000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 37581000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 54000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 37635000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 106675000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 60115000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 16126000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10504000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 30531000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 599000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -466000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total costs, expenses and other",
              "value": 58226000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 1889000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1512000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 377000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 12000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 365000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 365000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 0.14
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 0.14
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 0.14
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 0.14
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -97000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 385000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 89000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -393000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive (Loss) Income Attributable to Merck\u00a0& Co., Inc.",
              "value": -28000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 377000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 2044000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1800000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 792000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "(Income) loss from investments in equity securities, net",
              "value": 340000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionThree",
              "unit": "usd",
              "label": "Charge for the acquisition of Prometheus Biosciences, Inc.",
              "value": 10217000000
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of Imago BioSciences, Inc.",
              "value": 1192000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -1899000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 645000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -355000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 1148000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 816000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": -380000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 1783000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 214000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": 456000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 2314000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 13006000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3863000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireInvestments",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 955000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi",
              "unit": "usd",
              "label": "Proceeds from sale of Seagen Inc. common stock",
              "value": 1145000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1658000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFourNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Prometheus Biosciences, Inc., net of cash acquired",
              "value": 10705000000
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Imago BioSciences Inc., net of cash acquired",
              "value": 1327000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Acceleron Pharma Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 36000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -14083000000
            },
            {
              "concept": "us-gaap_RepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1755000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 5939000000
            },
            {
              "concept": "mrk_DisposalGroupIncludingDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1346000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 7445000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 125000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -328000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities of Continuing Operations",
              "value": -4810000000
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 23000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -5864000000
            }
          ]
        }
      },
      {
        "accessNumber": "0001628280-23-005061",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2022,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2022-01-01 00:00:00",
        "endDate": "2022-12-31 00:00:00",
        "filedDate": "2023-02-24 00:00:00",
        "acceptedDate": "2023-02-24 16:22:30",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 12694000000
            },
            {
              "concept": "us-gaap_ShortTermInvestments",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 498000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $72 in 2022 and $62 in 2021)",
              "value": 9450000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,938 in 2022 and $2,194 in 2021 classified in Other assets - see Note\u00a08)",
              "value": 5911000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 7169000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 35722000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1015000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 295000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 13166000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 16760000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 9186000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 39407000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 17985000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 21422000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21204000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20269000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 9528000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 109160000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 1946000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 4264000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 14159000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1986000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1884000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 24239000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 28745000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1795000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8323000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44379000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 61081000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4768000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 102480000000
            },
            {
              "concept": "us-gaap_TreasuryStockCommonValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,039,269,638 shares in 2022 and 1,049,499,023 shares in 2021",
              "value": 56489000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 45991000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 67000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 46058000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 109160000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 59283000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 17411000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10042000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 13548000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 337000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -1501000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total costs, expenses and other",
              "value": 42839000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 16444000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1918000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 14526000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 7000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 14519000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 0.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 14519000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 5.73
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 5.73
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 5.71
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 5.71
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -71000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": 0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -335000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -603000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -339000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 14180000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 14526000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 2085000000
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1800000000.0
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 1749000000
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Loss (income) from investments in equity securities, net",
              "value": -1419000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of VelosBio Inc.",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -1568000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 541000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -1301000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 644000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 161000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": -289000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -50000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 380000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -545000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 1473000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 19095000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 4388000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi",
              "unit": "usd",
              "label": "Purchase of Seagen Inc. common stock",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1204000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 721000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Acceleron Pharma Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFourNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of VelosBio Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 121000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -32000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -4960000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2251000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "mrk_DisposalGroupIncludingDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 7012000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 384000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -240000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Financing Activities of Continuing Operations",
              "value": -9119000000
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": 0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -410000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 4606000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-22-000003",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2021,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2021-01-01 00:00:00",
        "endDate": "2021-12-31 00:00:00",
        "filedDate": "2022-02-25 00:00:00",
        "acceptedDate": "2022-02-25 16:44:28",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8096000000.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $62 in 2021 and $67 in 2020)",
              "value": 9230000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,194 in 2021 and $2,070 in 2020 classified in Other assets - see Note\u00a08)",
              "value": 5953000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 6987000000.0
            },
            {
              "concept": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current assets of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 30266000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 370000000.0
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 326000000.0
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 12529000000.0
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 16303000000.0
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 8313000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 37471000000.0
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 18192000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 19279000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 21264000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 22933000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 11582000000.0
            },
            {
              "concept": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Assets of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 105694000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2412000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 4609000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 13859000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1224000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1768000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
              "unit": "usd",
              "label": "Current liabilities of discontinued operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 23872000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 30690000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 3441000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 9434000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
              "unit": "usd",
              "label": "Noncurrent Liabilities of Discontinued Operations",
              "value": 0.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 44238000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 53696000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4429000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 95293000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,049,499,023 shares in 2021 and 1,046,877,695 shares in 2020",
              "value": 57109000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 38184000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 73000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 38257000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 105694000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 48704000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 13626000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 9634000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 12245000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 661000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 1341000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total costs, expenses and other",
              "value": 34825000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income from Continuing Operations Before Taxes",
              "value": 13879000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income from Continuing Operations",
              "value": 1521000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 12358000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 13000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperations",
              "unit": "usd",
              "label": "Net Income from Continuing Operations Attributable to Merck\u00a0& Co., Inc.",
              "value": 12345000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
              "unit": "usd",
              "label": "Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests",
              "value": 704000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 13049000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 4.88
            },
            {
              "concept": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.28
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 5.16
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Continuing Operations (in dollars per share)",
              "value": 4.86
            },
            {
              "concept": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
              "unit": "usd/share",
              "label": "Income from Discontinued Operations (in dollars per share)",
              "value": 0.28
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Net Income (in dollars per share)",
              "value": 5.14
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 410000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": 0.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -1769000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -423000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 1756000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 14805000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income from Continuing Operations",
              "value": 12358000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1636000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1600000000.0
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 302000000.0
            },
            {
              "concept": "us-gaap_EquitySecuritiesFvNiGainLoss",
              "unit": "usd",
              "label": "Income from investments in equity securities, net",
              "value": 1940000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
              "unit": "usd",
              "label": "Charge for the acquisition of Pandion Therapeutics, Inc.",
              "value": 1556000000.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionTwo",
              "unit": "usd",
              "label": "Charge for the acquisition of VelosBio Inc.",
              "value": 0.0
            },
            {
              "concept": "mrk_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAssetAcquisitionThree",
              "unit": "usd",
              "label": "Charge for the acquisition of Peloton Therapeutics, Inc.",
              "value": 0.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 187000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 479000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -805000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 2033000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 674000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 405000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 277000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -540000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": 484000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 1758000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities of Continuing Operations",
              "value": 13122000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 4448000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi",
              "unit": "usd",
              "label": "Purchase of Seagen Inc. common stock",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 1000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 1026000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Acceleron Pharma Inc., net of cash acquired",
              "value": 11174000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Pandion Therapeutics, Inc., net of cash acquired",
              "value": 1554000000.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFourNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of VelosBio Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessSixNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessSevenNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Peloton Therapeutics, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 179000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 91000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities of Continuing Operations",
              "value": -16421000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3986000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2319000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 7936000000.0
            },
            {
              "concept": "mrk_DisposalGroupIncludingDiscontinuedOperationsDistributionReceived",
              "unit": "usd",
              "label": "Distribution from Organon & Co.",
              "value": 9000000000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 840000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 6610000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 202000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -286000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities of Continuing Operations",
              "value": 3097000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash provided by operating activities",
              "value": 987000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in investing activities",
              "value": -134000000.0
            },
            {
              "concept": "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
              "unit": "usd",
              "label": "Net cash used in financing activities",
              "value": -504000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations",
              "unit": "usd",
              "label": "Net Cash Flows Provided by Discontinued Operations",
              "value": 349000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -133000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 14000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-21-000004",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2020,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2020-01-01 00:00:00",
        "endDate": "2020-12-31 00:00:00",
        "filedDate": "2021-02-25 00:00:00",
        "acceptedDate": "2021-02-25 16:34:56",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8062000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 0.0
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $85 in 2020 and $86 in 2019)",
              "value": 7851000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $2,197 in 2020 and $1,480 in 2019 classified in Other assets - see Note\u00a07)",
              "value": 6310000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 5541000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 27764000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 785000000.0
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 350000000.0
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 12645000000.0
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 16649000000.0
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 7324000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 36968000000.0
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 18982000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 17986000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 20238000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 14604000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 10211000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 91588000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 6431000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 4594000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 13053000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1575000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1674000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 27327000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 25360000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1015000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12482000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39588000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 47362000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6634000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 82104000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,046,877,695 shares in 2020 and 1,038,087,496 shares in 2019",
              "value": 56787000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck\u00a0& Co., Inc. stockholders\u2019 equity",
              "value": 25317000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 87000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 25404000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 91588000000.0
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 47994000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 15485000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10468000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 13558000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 578000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 886000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total costs, expenses and other",
              "value": 39203000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 8791000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1709000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 7082000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income (Loss) Attributable to Noncontrolling Interests",
              "value": 15000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 7067000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck\u00a0& Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.79
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2.78
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -297000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -18000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 279000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 153000000.0
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -441000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck\u00a0& Co., Inc.",
              "value": 6626000000.0
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 7082000000.0
            },
            {
              "concept": "us-gaap_AdjustmentForAmortization",
              "unit": "usd",
              "label": "Amortization",
              "value": 1899000000.0
            },
            {
              "concept": "us-gaap_Depreciation",
              "unit": "usd",
              "label": "Depreciation",
              "value": 1700000000.0
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 1718000000.0
            },
            {
              "concept": "mrk_ChargeForAssetAcquisition",
              "unit": "usd",
              "label": "Charge for the acquisition of VelosBio Inc.",
              "value": 2660000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for the acquisition of Peloton Therapeutics, Inc.",
              "value": 0.0
            },
            {
              "concept": "mrk_ChargeForFuturePaymentsRelatedToCollaborationLicenseOptions",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 0.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -668000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 475000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 49000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 1002000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 855000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 724000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -1138000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 560000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -453000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 2426000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 10253000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 4684000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity",
              "unit": "usd",
              "label": "Purchase of Seagen Inc. common stock",
              "value": 1000000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 95000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 2812000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of VelosBio Inc., net of cash acquired",
              "value": 2696000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of ArQule, Inc., net of cash acquired",
              "value": 2545000000.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFourNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "mrk_PaymentsToAcquireBusinessFiveNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Peloton Therapeutics, Inc., net of cash acquired",
              "value": 0.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 1365000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -130000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -9443000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 2549000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1957000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4419000000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 1281000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 6215000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 89000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -436000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -2832000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 253000000.0
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash",
              "value": -1769000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-20-000005",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2019,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2019-01-01 00:00:00",
        "endDate": "2019-12-31 00:00:00",
        "filedDate": "2020-02-26 00:00:00",
        "acceptedDate": "2020-02-26 16:36:07",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 9676000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 774000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $86 in 2019 and $119 in 2018)",
              "value": 6778000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5978000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4277000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 27483000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 1469000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 343000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 11989000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 15394000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 5013000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 32739000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 17686000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 15053000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 19425000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 14196000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6771000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 84397000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3610000000
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3738000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 12549000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 736000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1587000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 22220000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-term debt",
              "value": 22736000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 1470000000.0
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": 11970000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39660000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 46602000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -6193000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 81857000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 1,038,087,496 shares in 2019 and 984,543,979 shares in 2018",
              "value": 55950000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 25907000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 94000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending Balance",
              "value": 26001000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 84397000000
            }
          ],
          "ic": [
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 46840000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 14112000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10615000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 9872000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 638000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -139000000.0
            },
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 35376000000
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 11464000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1687000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9777000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net (Loss) Income Attributable to Noncontrolling Interests",
              "value": -66000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net income attributable to Merck & Co., Inc.",
              "value": 9843000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 3.84
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders (in dollars per share)",
              "value": 3.81
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -135000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 96000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 705000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 96000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
              "unit": "usd",
              "label": "Other comprehensive income (loss)",
              "value": -648000000.0
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 9195000000
            }
          ],
          "cf": [
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 9777000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 3652000000
            },
            {
              "concept": "us-gaap_GoodwillAndIntangibleAssetImpairment",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 1040000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentInProcess",
              "unit": "usd",
              "label": "Charge for the acquisition of Peloton Therapeutics, Inc.",
              "value": 993000000
            },
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 0
            },
            {
              "concept": "us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense",
              "unit": "usd",
              "label": "Provisional charge for one-time transition tax related to the enactment of U.S. tax legislation",
              "value": 0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -556000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation cost",
              "value": 417000000.0
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -184000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": -294000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 508000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 399000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 376000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -2359000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -237000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 32000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 13440000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 3473000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 3202000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 8622000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Antelliq Corporation, net of cash acquired",
              "value": 3620000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Peloton Therapeutics, Inc., net of cash acquired",
              "value": 1040000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Other acquisitions, net of cash acquired",
              "value": 294000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -378000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -2629000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -3710000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 4958000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 4780000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5695000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Cash received from the exercise of stock options",
              "value": 361000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 5000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -8861000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": 17000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 1967000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-19-000014",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2018,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2018-01-01 00:00:00",
        "endDate": "2018-12-31 00:00:00",
        "filedDate": "2019-02-27 00:00:00",
        "acceptedDate": "2019-02-27 16:36:42",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3318000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $119 in 2018 and $159 in 2017)",
              "value": 7071000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1971000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 16324000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -5545000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 38808000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 82637000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 25875000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 11486000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7965000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 3355000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt",
              "value": 5308000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 1702000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 7554000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1458000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill, Ending Balance",
              "value": 18253000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Net",
              "value": 11431000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,417 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)",
              "value": 5440000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 333000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 82637000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 22206000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 19806000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 14441000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 899000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 6233000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 181000000
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4500000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10151000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 12041000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 29615000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 13291000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 42579000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 26701000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 77630000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 26882000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 984,543,979 shares in 2018 and 880,491,914 shares in 2017",
              "value": 50929000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 33593000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 5859000000
            },
            {
              "concept": "us-gaap_CostOfGoodsAndServicesSold",
              "unit": "usd",
              "label": "Cost of sales",
              "value": 13509000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 2
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 8701000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on income",
              "value": 2508000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 6220000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net (Loss) Income Attributable to Noncontrolling Interests",
              "value": -27000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": -10000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 297000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -223000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -361000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 425000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 402000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 6193000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 9752000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 632000000
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Sales",
              "value": 42294000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, general and administrative",
              "value": 10102000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to collaboration license options",
              "value": 650000000
            },
            {
              "concept": "mrk_TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Charge for one-time transition tax related to Tax Cuts and Jobs Act of 2017",
              "value": 0
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 296000000
            },
            {
              "concept": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash",
              "value": 1871000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -509000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 4519000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash",
              "value": -205000000
            },
            {
              "concept": "us-gaap_GainLossRelatedToLitigationSettlement",
              "unit": "usd",
              "label": "Charge related to the settlement of worldwide Keytruda patent litigation",
              "value": 0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 230000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 418000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 827000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -341000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 911000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 674000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -266000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -13160000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 4314000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 10922000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -978000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -102000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 9091000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5172000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisitions, net of cash acquired",
              "value": 431000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 7994000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 2615000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -325000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 5124000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 15252000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Cash received from the exercise of stock options",
              "value": 591000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 6193000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 4287000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation cost",
              "value": 348000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-18-000005",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2017,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2017-01-01 00:00:00",
        "endDate": "2017-12-31 00:00:00",
        "filedDate": "2018-02-27 00:00:00",
        "acceptedDate": "2018-02-27 16:33:07",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 3102000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $210 in 2017 and $195 in 2016)",
              "value": 6873000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 708000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 16602000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -4910000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39902000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 87872000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 24766000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 11726000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Year",
              "value": 6092000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 2301000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 3057000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 2219000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6075000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1320000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 18284000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other intangibles, net",
              "value": 14183000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 5096000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 365000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 87872000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18614000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 21353000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 14649000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 2406000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 12125000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 233000000
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4299000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10427000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Liability",
              "value": 11117000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 29041000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 12439000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 41350000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 34336000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 78130000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending Balance",
              "value": 34569000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 880,491,914 shares in 2017 and 828,372,200 shares in 2016",
              "value": 43794000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 33601000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 2710000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 12775000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 6521000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 4103000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 2394000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 24000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized loss on investments, net of reclassifications",
              "value": -58000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized loss on derivatives, net of reclassifications",
              "value": -446000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": 401000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 316000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -419000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -12000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2418000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 10208000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 776000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 40122000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 9830000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ChargeForLicenseOptionsRelatedToCollaboration",
              "unit": "usd",
              "label": "Charge for future payments related to AstraZeneca collaboration license options",
              "value": 500000000
            },
            {
              "concept": "mrk_TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Provisional charge for one-time transition tax related to the enactment of U.S. tax legislation",
              "value": 5347000000.0
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 646000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -423000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": -2621000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 4637000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": 457000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity method affiliates",
              "value": 2000000
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign exchange losses related to Venezuela",
              "value": 0
            },
            {
              "concept": "us-gaap_GainLossRelatedToLitigationSettlement",
              "unit": "usd",
              "label": "Charge related to the settlement of worldwide Keytruda patent litigation",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 42000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 254000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": -297000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -3291000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -922000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": 145000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 1091000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -123000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -10006000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Investing Activities",
              "value": 2679000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 6447000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -269000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -38000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 4014000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5167000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to acquire business, net of cash acquired",
              "value": 396000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 10739000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1888000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -195000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -26000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 15664000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Cash received from the exercise of stock options",
              "value": 499000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 2418000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1103000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation cost",
              "value": 312000000
            },
            {
              "concept": "us-gaap_UnusualOrInfrequentItemNetOfInsuranceProceeds",
              "unit": "usd",
              "label": "Net charge related to the settlement of Vioxx shareholder class action litigation",
              "value": 0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-17-000010",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2016,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2016-01-01 00:00:00",
        "endDate": "2016-12-31 00:00:00",
        "filedDate": "2017-02-28 00:00:00",
        "acceptedDate": "2017-02-28 16:33:13",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2807000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $195 in 2016 and $165 in 2015) (excludes accounts receivable of $10 in 2015 classified in Other assets)",
              "value": 7018000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 2239000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 15749000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income (Loss), ending balance",
              "value": -5226000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 39939000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 95377000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 30614000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 11439000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents at End of Year",
              "value": 6515000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2016 and 2015",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 1871000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 568000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5854000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 5077000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1316000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill, Ending Balance",
              "value": 18162000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other intangibles, net",
              "value": 17305000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 4866000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 412000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 95377000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 17204000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-term debt",
              "value": 24274000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 14053000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 7826000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 11416000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 220000000
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 4389000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10274000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Liability",
              "value": 8514000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, plant and equipment (at cost)",
              "value": 27775000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, plant and equipment, net",
              "value": 12026000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 44133000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 40088000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 80634000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending Balance",
              "value": 40308000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 828,372,200 shares in 2016 and 795,975,449 shares in 2015",
              "value": 40546000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 35148000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 2842000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 13891000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 4659000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 718000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 3920000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 21000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -44000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -66000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -169000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -1078000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 799000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -720000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3941000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 10124000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 651000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 39807000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 9762000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ProceedsFromDivestitureOfBusinessTwoNetOfCashDivested",
              "unit": "usd",
              "label": "Divestiture of Merck Consumer Care business, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 3948000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -2009000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -1521000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 5441000000
            },
            {
              "concept": "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on divestiture of Merck Consumer Care",
              "value": 0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -131000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity method affiliates",
              "value": 16000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign currency devaluation related to Venezuela",
              "value": 0
            },
            {
              "concept": "us-gaap_GainLossRelatedToLitigationSettlement",
              "unit": "usd",
              "label": "Charge related to the settlement of worldwide Keytruda patent litigation",
              "value": -625000000
            },
            {
              "concept": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
              "unit": "usd",
              "label": "Loss on extinguishment of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 86000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 278000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 619000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 124000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -2018000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": -206000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": -237000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -809000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -9044000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -3210000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 10376000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -313000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities",
              "unit": "usd",
              "label": "Cash inflows from net investment hedges",
              "value": -29000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -453000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 3434000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5124000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsMinorityInterest",
              "unit": "usd",
              "label": "Other dividends paid",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Idenix Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to acquire business, net of cash acquired",
              "value": 780000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireIntangibleAssets",
              "unit": "usd",
              "label": "Payment to Bayer AG for collaboration rights",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 15651000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1614000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of other businesses, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 1079000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -118000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 14353000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 939000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 3941000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 2386000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 300000000
            },
            {
              "concept": "us-gaap_UnusualOrInfrequentItemNetOfInsuranceProceeds",
              "unit": "usd",
              "label": "Net charge related to the settlement of Vioxx shareholder class action litigation",
              "value": 0
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-16-000063",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2015,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2015-01-01 00:00:00",
        "endDate": "2015-12-31 00:00:00",
        "filedDate": "2016-02-26 00:00:00",
        "acceptedDate": "2016-02-26 16:04:31",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2533000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $165 in 2015 and $153 in 2014) (excludes accounts receivable of $10 in 2015 and $80 in 2014 classified in Other assets - see Note 5)",
              "value": 6484000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1560000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 15923000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4148000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40222000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 101779000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 29764000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 12154000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 8524000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2015 and 2014",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 1525000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2585000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 6144000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6535000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1309000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill, Ending Balance",
              "value": 17723000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Net",
              "value": 22602000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories",
              "value": 4700000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 490000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 101779000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 19203000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 23929000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 14261000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 4903000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13039000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 91000000
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Other current assets",
              "value": 5153000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 11216000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7345000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Gross",
              "value": 28430000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net, Total",
              "value": 12507000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 45348000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 44676000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83210000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Total equity",
              "value": 44767000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 795,975,449 shares in 2015 and 738,963,326 shares in 2014",
              "value": 38534000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 34097000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 4617000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 14934000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic earnings per common share attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Earnings per common share assuming dilution attributable to Merck & Co., Inc. common shareholders, in dollars per share",
              "value": 1
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 5401000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 942000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4442000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Less: Net Income Attributable to Noncontrolling Interests",
              "value": 17000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on investments, net of reclassifications",
              "value": -70000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized (loss) gain on derivatives, net of reclassifications",
              "value": -126000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -208000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 175000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net gain (loss) and prior service credit (cost), net of amortization",
              "value": -579000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -1527000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 4459000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 6704000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 619000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 39498000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 10313000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ProceedsFromDivestitureOfBusinessTwoNetOfCashDivested",
              "unit": "usd",
              "label": "Divestiture of Merck Consumer Care business, net of cash divested",
              "value": 0
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 162000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 1083000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -764000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 6375000000
            },
            {
              "concept": "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on divestiture of Merck Consumer Care business",
              "value": 0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -1310000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity method affiliates",
              "value": 50000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on disposition of interest in equity method investment",
              "value": 0
            },
            {
              "concept": "us-gaap_ForeignCurrencyTransactionGainLossRealized",
              "unit": "usd",
              "label": "Foreign currency devaluation related to Venezuela",
              "value": -876000000
            },
            {
              "concept": "us-gaap_GainLossRelatedToLitigationSettlement",
              "unit": "usd",
              "label": "Net charge related to the settlement of Vioxx shareholder class action litigation",
              "value": -680000000
            },
            {
              "concept": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
              "unit": "usd",
              "label": "Loss on extinguishment of debt",
              "value": 0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 205000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": -37000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 480000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -266000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -8000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": -805000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 5000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -277000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -5270000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -4758000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 12421000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": -757000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities",
              "unit": "usd",
              "label": "Cash inflows from net investment hedges",
              "value": -139000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -82000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 4186000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5117000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsMinorityInterest",
              "unit": "usd",
              "label": "Other dividends paid",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Idenix Pharmaceuticals, Inc., net of cash acquired",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Cubist Pharmaceuticals, Inc., net of cash acquired",
              "value": 7598000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to acquire business, net of cash acquired",
              "value": 146000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireIntangibleAssets",
              "unit": "usd",
              "label": "Payment to Bayer AG for collaboration rights",
              "value": 0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 16681000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1283000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of other businesses, net of cash divested",
              "value": 316000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 7938000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 56000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -1540000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 20413000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 485000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 4459000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Repayments of Long-term Debt",
              "value": 2906000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Pretax share-based compensation cost",
              "value": 299000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-15-000005",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2014,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2014-01-01 00:00:00",
        "endDate": "2014-12-31 00:00:00",
        "filedDate": "2015-02-27 00:00:00",
        "acceptedDate": "2015-02-27 14:02:50",
        "report": {
          "bs": [
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2625000000
            },
            {
              "concept": "us-gaap_AccountsReceivableNetCurrent",
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $153 in 2014 and $146 in 2013) (excludes accounts receivable of $80 in 2014 and $275 in 2013 classified in Other assets - see Note 5)",
              "value": 6626000000
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1606000000
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 18004000000
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -4323000000
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40423000000
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 98335000000
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 33173000000
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings",
              "value": 13101000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 7441000000
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2014 and 2013",
              "value": 1788000000
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in progress",
              "value": 1448000000
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 2704000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 5257000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5133000000
            },
            {
              "concept": "us-gaap_DeferredTaxLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 4266000000
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1308000000
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12992000000
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 20386000000
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,664 in 2014 and $1,704 in 2013 classified in Other assets - see Note 6)",
              "value": 5571000000
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 541000000
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Equity",
              "value": 98335000000
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 18766000000
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 18699000000
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 16050000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 8278000000
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 13515000000
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Noncontrolling Interests",
              "value": 144000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesCurrent",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 10523000000
            },
            {
              "concept": "us-gaap_OtherLiabilitiesNoncurrent",
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 7813000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Gross",
              "value": 31140000000
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 13136000000
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained earnings",
              "value": 46021000000
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Total Merck & Co., Inc. stockholders\u2019 equity",
              "value": 48647000000
            },
            {
              "concept": "us-gaap_StockholdersEquityBeforeTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 83909000000
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Ending Balance",
              "value": 48791000000
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Less treasury stock, at cost: 738,963,326 shares in 2014 and 649,576,808 shares in 2013",
              "value": 35262000000
            }
          ],
          "ic": [
            {
              "concept": "mrk_CostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 24954000000
            },
            {
              "concept": "us-gaap_ComprehensiveIncomeNetOfTax",
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 9794000000
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Materials and production",
              "value": 16768000000
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usd/share",
              "label": "Basic Earnings per Common Share (in dollars per share)",
              "value": 4
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usd/share",
              "label": "Diluted Earnings per Common Share (in dollars per share)",
              "value": 4
            },
            {
              "concept": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 17283000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 257000000
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Taxes on income",
              "value": 5349000000
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 11920000000
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 14000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on investments, net of reclassifications",
              "value": 57000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
              "unit": "usd",
              "label": "Net unrealized gain (loss) on derivatives, net of reclassifications",
              "value": 398000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Cumulative translation adjustment",
              "value": -504000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": -2126000000
            },
            {
              "concept": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
              "unit": "usd",
              "label": "Benefit plan net (loss) gain and prior service (cost) credit, net of amortization",
              "value": 2077000000
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": 11356000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 11934000000
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and development",
              "value": 7180000000
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 1013000000
            },
            {
              "concept": "us-gaap_SalesRevenueGoodsNet",
              "unit": "usd",
              "label": "Sales",
              "value": 42237000000
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 11606000000
            }
          ],
          "cf": [
            {
              "concept": "mrk_ProceedsFromDivestitureOfBusinessTwoNetOfCashDivested",
              "unit": "usd",
              "label": "Proceeds from divestiture of business, net",
              "value": 13951000000
            },
            {
              "concept": "us-gaap_AssetImpairmentCharges",
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 1222000000
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Net (Decrease) Increase in Cash and Cash Equivalents",
              "value": -8180000000
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -2600000000
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 6691000000
            },
            {
              "concept": "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on divestiture of Merck Consumer Care",
              "value": 11209000000
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -553000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity method affiliates",
              "value": 185000000
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
              "unit": "usd",
              "label": "Gain on AstraZeneca option exercise",
              "value": 741000000
            },
            {
              "concept": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
              "unit": "usd",
              "label": "Loss on extinguishment of debt",
              "value": -628000000
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 257000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 593000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Accounts receivable",
              "value": 554000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -21000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedLiabilities",
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 1635000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Inventories",
              "value": -79000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Other",
              "value": 98000000
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": 190000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Financing Activities",
              "value": -15113000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash Used in Investing Activities",
              "value": -374000000
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 7860000000
            },
            {
              "concept": "us-gaap_OtherNoncashIncomeExpense",
              "unit": "usd",
              "label": "Other",
              "value": 95000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromHedgeInvestingActivities",
              "unit": "usd",
              "label": "Cash inflows from net investment hedges",
              "value": -195000000
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 80000000
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 7703000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5170000000
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsMinorityInterest",
              "unit": "usd",
              "label": "Other dividends paid",
              "value": 77000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired",
              "unit": "usd",
              "label": "Acquisition of Idenix Pharmaceuticals, Inc., net of cash acquired",
              "value": 3700000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 181000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireIntangibleAssets",
              "unit": "usd",
              "label": "Payments to Acquire Intangible Assets",
              "value": 1000000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireMarketableSecurities",
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 24944000000
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1317000000
            },
            {
              "concept": "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
              "unit": "usd",
              "label": "Dispositions of other businesses, net of cash divested",
              "value": 1169000000
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 3146000000
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": 208000000
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebt",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -460000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 15114000000
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds from AstraZeneca option exercise",
              "value": 419000000
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 1560000000
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net income",
              "value": 11934000000
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 6617000000
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share-based compensation",
              "value": 278000000
            }
          ]
        }
      },
      {
        "accessNumber": "0000310158-14-000009",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2013,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2013-01-01 00:00:00",
        "endDate": "2013-12-31 00:00:00",
        "filedDate": "2014-02-27 00:00:00",
        "acceptedDate": "2014-02-27 16:59:59",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "Cash and cash equivalents",
              "value": 15621000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1865000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts receivable (net of allowance for doubtful accounts of $146 in 2013 and $163 in 2012) (excludes accounts receivable of $275 in 2013 and $473 in 2012 classified in Other assets - see Note 5)",
              "value": 7184000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,704 in 2013 and $1,606 in 2012 classified in Other assets - see Note 6)",
              "value": 6226000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 4789000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Current Assets",
              "value": 35685000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Investments",
              "value": 9770000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Land",
              "value": 550000000,
              "concept": "Land"
            },
            {
              "unit": "usd",
              "label": "Buildings",
              "value": 13627000000,
              "concept": "BuildingsAndImprovementsGross"
            },
            {
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 17106000000,
              "concept": "MachineryAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "Construction in progress",
              "value": 1811000000,
              "concept": "ConstructionInProgressGross"
            },
            {
              "unit": "usd",
              "label": "Property, Plant and Equipment (at cost)",
              "value": 33094000000,
              "concept": "PropertyPlantAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "Less: accumulated depreciation",
              "value": 18121000000,
              "concept": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
            },
            {
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net, Total",
              "value": 14973000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "Consideration Transfered in Business Divestiture - Goodwill Reduction",
              "value": 12301000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 23801000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "Other Assets",
              "value": 9115000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Assets",
              "value": 105645000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 4521000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2274000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 9501000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 251000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "Dividends payable",
              "value": 1321000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Current Liabilities",
              "value": 17868000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 20539000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes",
              "value": 6776000000,
              "concept": "DeferredTaxLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Other Noncurrent Liabilities",
              "value": 8136000000,
              "concept": "OtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2013 and 2012",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "Other paid-in capital",
              "value": 40508000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "Retained earnings",
              "value": 39257000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -2197000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 79356000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "Treasury stock shares purchased",
              "value": 29591000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "Beginning Balance",
              "value": 49765000000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 2561000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Beginning Balance",
              "value": 52326000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Liabilities and Equity",
              "value": 105645000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "Net Income",
              "value": 4517000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Depreciation and amortization",
              "value": 6988000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "Intangible asset impairment charges",
              "value": 765000000,
              "concept": "AssetImpairmentCharges"
            },
            {
              "unit": "usd",
              "label": "Gain on disposition of interest in equity method investment",
              "value": 0,
              "concept": "EquityMethodInvestmentRealizedGainLossOnDisposal"
            },
            {
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 404000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 237000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred provision",
              "value": -330000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Award Type [Domain]",
              "value": 276000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": -399000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Accounts receivable",
              "value": -436000000,
              "concept": "IncreaseDecreaseInAccountsReceivable"
            },
            {
              "unit": "usd",
              "label": "Inventories",
              "value": 365000000,
              "concept": "IncreaseDecreaseInInventories"
            },
            {
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 522000000,
              "concept": "IncreaseDecreaseInAccountsPayableTrade"
            },
            {
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -397000000,
              "concept": "IncreaseDecreaseInAccruedLiabilities"
            },
            {
              "unit": "usd",
              "label": "Income taxes payable",
              "value": -1421000000,
              "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable"
            },
            {
              "unit": "usd",
              "label": "Noncurrent liabilities",
              "value": -132000000,
              "concept": "IncreaseDecreaseInOtherOperatingLiabilities"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": -563000000,
              "concept": "IncreaseDecreaseInOtherOperatingCapitalNet"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Operating Activities",
              "value": 11654000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1548000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 17991000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 16298000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sale of interest in equity method investment",
              "value": 0,
              "concept": "ProceedsFromSaleOfEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Acquisitions of businesses, net of cash acquired",
              "value": 246000000,
              "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired"
            },
            {
              "unit": "usd",
              "label": "Dispositions of businesses, net of cash divested",
              "value": 46000000,
              "concept": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested"
            },
            {
              "unit": "usd",
              "label": "Cash inflows (outflows) from net investment hedges",
              "value": -350000000,
              "concept": "PaymentsForProceedsFromHedgeInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": 57000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Investing Activities",
              "value": -3148000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": -159000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1775000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Proceeds from issuance of debt",
              "value": 6467000000,
              "concept": "ProceedsFromIssuanceOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Purchases of treasury stock",
              "value": 6516000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 5157000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Other dividends paid",
              "value": 120000000,
              "concept": "PaymentsOfDividendsMinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 1210000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "Other",
              "value": 60000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Cash Flows from Financing Activities",
              "value": -5990000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -346000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "Net Increase (Decrease) in Cash and Cash Equivalents",
              "value": 2170000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            }
          ],
          "ic": [
            {
              "unit": "usd",
              "label": "Net Income Attributable to Merck & Co., Inc.",
              "value": 4404000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "Derivatives, Other comprehensive income (loss), net of taxes",
              "value": 229000000,
              "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Investments, Other comprehensive income (loss), net of taxes",
              "value": -19000000,
              "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Employee Benefit Plans, Other comprehensive income (loss), net of taxes",
              "value": -2758000000,
              "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Cumulative Translation Adjustment, Other comprehensive income (loss), net of taxes",
              "value": -483000000,
              "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other comprehensive income (loss), net of taxes",
              "value": 2485000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Comprehensive Income Attributable to Merck & Co., Inc.",
              "value": 6889000000,
              "concept": "ComprehensiveIncomeNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Sales",
              "value": 44033000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd",
              "label": "Materials and production",
              "value": 16954000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Marketing and administrative",
              "value": 11911000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "Research and development",
              "value": 7503000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "Restructuring costs",
              "value": 1709000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 404000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Other (income) expense, net",
              "value": -815000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 38488000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 5545000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Taxes on Income",
              "value": 1028000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Net Income",
              "value": 4517000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net income attributable to noncontrolling interests",
              "value": 113000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd/shares",
              "label": "Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.49,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)",
              "value": 1.47,
              "concept": "EarningsPerShareDiluted"
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-13-084618",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2012,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2012-01-01 00:00:00",
        "endDate": "2012-12-31 00:00:00",
        "filedDate": "2013-02-28 00:00:00",
        "acceptedDate": "2013-02-28 16:54:26",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "Marketable Securities Noncurrent",
              "value": 7305000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
              "value": 17385000000,
              "concept": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
            },
            {
              "unit": "usd",
              "label": "Property Plant And Equipment Net",
              "value": 16030000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "Goodwill",
              "value": 12134000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "Intangible Assets Net Excluding Goodwill",
              "value": 29083000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Assets Noncurrent",
              "value": 6723000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Assets",
              "value": 106132000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Cash And Cash Equivalents At Carrying Value",
              "value": 13451000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities Current",
              "value": 2690000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts Receivable Net Current",
              "value": 7672000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventory Net",
              "value": 6535000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Assets Current",
              "value": 4509000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Assets Current",
              "value": 34857000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Long Term Debt Noncurrent",
              "value": 16254000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes And Other Liabilities Noncurrent",
              "value": 16067000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2443000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest",
              "value": 55463000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Liabilities And Stockholders Equity",
              "value": 106132000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Debt Current",
              "value": 4315000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "Accounts Payable Current",
              "value": 1753000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Other Liabilities Current",
              "value": 9737000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Accrued Income Taxes Current",
              "value": 1200000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "Dividends Payable Current",
              "value": 1343000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Liabilities Current",
              "value": 18348000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Land",
              "value": 591000000,
              "concept": "Land"
            },
            {
              "unit": "usd",
              "label": "Buildings And Improvements Gross",
              "value": 13196000000,
              "concept": "BuildingsAndImprovementsGross"
            },
            {
              "unit": "usd",
              "label": "Machinery And Equipment Gross",
              "value": 17188000000,
              "concept": "MachineryAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "Construction In Progress Gross",
              "value": 2440000000,
              "concept": "ConstructionInProgressGross"
            },
            {
              "unit": "usd",
              "label": "Property Plant And Equipment Gross",
              "value": 33415000000,
              "concept": "PropertyPlantAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "Common Stock Value",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "Additional Paid In Capital Common Stock",
              "value": 40646000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings Accumulated Deficit",
              "value": 39985000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
              "value": -4682000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity Before Treasury Stock",
              "value": 77737000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "Treasury Stock Value",
              "value": 24717000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 53020000000,
              "concept": "StockholdersEquity"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "Depreciation Depletion And Amortization",
              "value": 6978000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "Asset Impairment Charges",
              "value": 200000000,
              "concept": "AssetImpairmentCharges"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 642000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Equity Method Investment Dividends Or Distributions",
              "value": 291000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense Benefit",
              "value": 669000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Share Based Compensation",
              "value": 335000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "Other Noncash Income Expense",
              "value": -28000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Accounts Receivable",
              "value": -349000000,
              "concept": "IncreaseDecreaseInAccountsReceivable"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Inventories",
              "value": 482000000,
              "concept": "IncreaseDecreaseInInventories"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Accounts Payable Trade",
              "value": -302000000,
              "concept": "IncreaseDecreaseInAccountsPayableTrade"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Accrued Liabilities",
              "value": -717000000,
              "concept": "IncreaseDecreaseInAccruedLiabilities"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Accrued Income Taxes Payable",
              "value": -34000000,
              "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Other Operating Liabilities",
              "value": -1747000000,
              "concept": "IncreaseDecreaseInOtherOperatingLiabilities"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Other Operating Capital Net",
              "value": 1203000000,
              "concept": "IncreaseDecreaseInOtherOperatingCapitalNet"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Repayments Of Short Term Debt",
              "value": 624000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "Repayments Of Long Term Debt",
              "value": 22000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Issuance Of Long Term Debt",
              "value": 2562000000,
              "concept": "ProceedsFromIssuanceOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Payments For Repurchase Of Common Stock",
              "value": 2591000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "Payments Of Dividends Common Stock",
              "value": 5116000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Payments Of Dividends Minority Interest",
              "value": 120000000,
              "concept": "PaymentsOfDividendsMinorityInterest"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Stock Options Exercised",
              "value": 1310000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Payments For Other Financing Activities",
              "value": 86000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Financing Activities",
              "value": -3267000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "Payments To Acquire Productive Assets",
              "value": 1954000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Payments To Acquire Marketable Securities",
              "value": 12841000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "Proceeds From Sale Maturity And Collections Of Investments",
              "value": 7783000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Increase Decrease In Restricted Cash And Investments",
              "value": -34000000,
              "concept": "IncreaseDecreaseInRestrictedCashAndInvestments"
            },
            {
              "unit": "usd",
              "label": "Payments For Proceeds From Other Investing Activities",
              "value": -173000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Investing Activities",
              "value": -6805000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "Profit Loss",
              "value": 6299000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net Cash Provided By Used In Operating Activities",
              "value": 10022000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "Effect Of Exchange Rate On Cash And Cash Equivalents",
              "value": -30000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "Cash And Cash Equivalents Period Increase Decrease",
              "value": -80000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            }
          ],
          "ic": [
            {
              "unit": "usd",
              "label": "Cost Of Goods Sold",
              "value": 16446000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Selling General And Administrative Expense",
              "value": 12776000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "Research And Development Expense",
              "value": 8168000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 664000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Equity Method Investments",
              "value": 642000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Other Nonoperating Income Expense",
              "value": -1116000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Costs, expenses and other.",
              "value": 38528000000,
              "concept": "mrk:CostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
              "value": 8739000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Income Tax Expense Benefit",
              "value": 2440000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "Profit Loss",
              "value": 6299000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Net Income Loss Attributable To Noncontrolling Interest",
              "value": 131000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 6168000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "Sales Revenue Goods Net",
              "value": 47267000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings Per Share Basic",
              "value": 2.03,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "Earnings Per Share Diluted",
              "value": 2,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax",
              "value": -101000000,
              "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
              "value": 52000000,
              "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax",
              "value": 1321000000,
              "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax",
              "value": -180000000,
              "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Other Comprehensive Income Loss Net Of Tax",
              "value": -1550000000,
              "concept": "OtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest",
              "value": 4618000000,
              "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"
            }
          ]
        }
      },
      {
        "accessNumber": "0001193125-12-084319",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2011,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2011-01-01 00:00:00",
        "endDate": "2011-12-31 00:00:00",
        "filedDate": "2012-02-28 00:00:00",
        "acceptedDate": "2012-02-28 13:09:51",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "",
              "value": 13531000000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1441000000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 6254000000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12155000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 34302000000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105128000000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Debt, Current",
              "value": 1990000000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2462000000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 781000000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1281000000,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15525000000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 23792000000,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2426000000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 56943000000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16245000000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 33181000000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Marketable Securities, Noncurrent",
              "value": 3458000000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8261000000,
              "concept": "AccountsReceivableNetCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3694000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5735000000,
              "concept": "DeferredIncomeTaxesAndOtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 9731000000,
              "concept": "OtherLiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 78309000000,
              "concept": "StockholdersEquityBeforeTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -3132000000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 38990000000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 40663000000,
              "concept": "AdditionalPaidInCapitalCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1788000000,
              "concept": "CommonStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16415000000,
              "concept": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 105128000000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 54517000000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16297000000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16176000000,
              "concept": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 32473000000,
              "concept": "PropertyPlantAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2198000000,
              "concept": "ConstructionInProgressGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16919000000,
              "concept": "MachineryAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12733000000,
              "concept": "BuildingsAndImprovementsGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 623000000,
              "concept": "Land"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "",
              "value": 6392000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 610000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 216000000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Tax Expense (Benefit)",
              "value": -1537000000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 369000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -323000000,
              "concept": "OtherNoncashIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1723000000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Sale, Maturity and Collection of Investments",
              "value": 6149000000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 116000000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -2890000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1547000000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4691000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 321000000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -22000000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -6904000000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 42000000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2631000000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12383000000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7427000000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 323000000,
              "concept": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1921000000,
              "concept": "PaymentsForRepurchaseOfCommonStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7325000000,
              "concept": "PaymentsToAcquireMarketableSecurities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1076000000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebt"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 136000000,
              "concept": "EquityMethodInvestmentRealizedGainLossOnDisposal"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 262000000,
              "concept": "IncreaseDecreaseInOtherOperatingCapitalNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -7000000,
              "concept": "IncreaseDecreaseInOtherOperatingLiabilities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -277000000,
              "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 182000000,
              "concept": "IncreaseDecreaseInAccountsPayableTrade"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 678000000,
              "concept": "IncreaseDecreaseInInventories"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1168000000,
              "concept": "IncreaseDecreaseInAccountsReceivable"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 175000000,
              "concept": "ProceedsFromSaleOfEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 373000000,
              "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired"
            },
            {
              "unit": "usd",
              "label": "Other Dividends Paid",
              "value": 120000000,
              "concept": "mrk:OtherDividendsPaid"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1444000000,
              "concept": "IncreaseDecreaseInAccruedLiabilities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 705000000,
              "concept": "AssetImpairmentCharges"
            }
          ],
          "ic": [
            {
              "unit": "usd/shares",
              "label": "",
              "value": 2.04,
              "concept": "EarningsPerShareBasic"
            },
            {
              "unit": "usd/shares",
              "label": "",
              "value": 2.02,
              "concept": "EarningsPerShareDiluted"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6272000000,
              "concept": "NetIncomeLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 120000000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 6392000000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 942000000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7334000000,
              "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 48047000000,
              "concept": "SalesRevenueGoodsNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -946000000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 610000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1306000000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8467000000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 13733000000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 16871000000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "Costs Expenses And Other",
              "value": 40713000000,
              "concept": "mrk:CostsExpensesAndOther"
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-11-019286",
        "symbol": "MRK",
        "cik": "310158",
        "year": 2010,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2010-01-01 00:00:00",
        "endDate": "2010-12-31 00:00:00",
        "filedDate": "2011-02-28 00:00:00",
        "acceptedDate": "2011-02-28 08:05:34",
        "report": {
          "bs": [
            {
              "concept": "mrk_AccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Accrued And Other Current Liabilities",
              "value": 8514000000.0
            },
            {
              "concept": "mrk_DeferredTaxesAndNoncurrentLiabilities",
              "unit": "usd",
              "label": "Deferred Taxes And Noncurrent Liabilities",
              "value": 17853000000.0
            },
            {
              "concept": "mrk_SixPercentMandatoryConvertiblePreferredStock",
              "unit": "usd",
              "label": "Six Percent Mandatory convertible preferred stock",
              "value": 0.0
            },
            {
              "concept": "mrk_StockholdersEquityBeforeDeductionForTreasuryStock",
              "unit": "usd",
              "label": "Stockholders' Equity Before Deduction For Treasury Stock",
              "value": 76809000000.0
            },
            {
              "concept": "us-gaap_AccountsPayableCurrent",
              "unit": "usd",
              "label": "Trade accounts payable",
              "value": 2308000000.0
            },
            {
              "concept": "us-gaap_AccruedIncomeTaxesCurrent",
              "unit": "usd",
              "label": "Income taxes payable",
              "value": 1243000000.0
            },
            {
              "concept": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
              "unit": "usd",
              "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
              "value": 13481000000.0
            },
            {
              "concept": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
              "unit": "usd",
              "label": "Accumulated other comprehensive loss",
              "value": -3216000000.0
            },
            {
              "concept": "us-gaap_AdditionalPaidInCapitalCommonStock",
              "unit": "usd",
              "label": "Additional Paid in Capital, Common Stock",
              "value": 40701000000.0
            },
            {
              "concept": "us-gaap_Assets",
              "unit": "usd",
              "label": "Total Assets",
              "value": 105781000000.0
            },
            {
              "concept": "us-gaap_AssetsCurrent",
              "unit": "usd",
              "label": "Total current assets",
              "value": 29064000000.0
            },
            {
              "concept": "us-gaap_BuildingsAndImprovementsGross",
              "unit": "usd",
              "label": "Buildings and Improvements, Gross",
              "value": 11945000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, at Carrying Value",
              "value": 10900000000.0
            },
            {
              "concept": "us-gaap_CommonStockValue",
              "unit": "usd",
              "label": "Common Stock Value",
              "value": 1788000000.0
            },
            {
              "concept": "us-gaap_ConstructionInProgressGross",
              "unit": "usd",
              "label": "Construction in Progress, Gross",
              "value": 2066000000.0
            },
            {
              "concept": "us-gaap_DebtCurrent",
              "unit": "usd",
              "label": "Debt, Current",
              "value": 2400000000.0
            },
            {
              "concept": "us-gaap_DividendsPayableCurrent",
              "unit": "usd",
              "label": "Dividends Payable, Current",
              "value": 1176000000.0
            },
            {
              "concept": "us-gaap_Goodwill",
              "unit": "usd",
              "label": "Goodwill",
              "value": 12378000000.0
            },
            {
              "concept": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
              "unit": "usd",
              "label": "Other Intangibles, Net",
              "value": 39456000000.0
            },
            {
              "concept": "us-gaap_InventoryNet",
              "unit": "usd",
              "label": "Inventory, Net",
              "value": 5868000000.0
            },
            {
              "concept": "us-gaap_Land",
              "unit": "usd",
              "label": "Land",
              "value": 658000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesAndStockholdersEquity",
              "unit": "usd",
              "label": "Total Liabilities and Stockholders' Equity",
              "value": 105781000000.0
            },
            {
              "concept": "us-gaap_LiabilitiesCurrent",
              "unit": "usd",
              "label": "Total current liabilities",
              "value": 15641000000.0
            },
            {
              "concept": "us-gaap_LongTermDebtNoncurrent",
              "unit": "usd",
              "label": "Long-Term Debt",
              "value": 15482000000.0
            },
            {
              "concept": "us-gaap_MachineryAndEquipmentGross",
              "unit": "usd",
              "label": "Machinery and Equipment, Gross",
              "value": 15894000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesCurrent",
              "unit": "usd",
              "label": "Short-term investments",
              "value": 1301000000.0
            },
            {
              "concept": "us-gaap_MarketableSecuritiesNoncurrent",
              "unit": "usd",
              "label": "Investments",
              "value": 2175000000.0
            },
            {
              "concept": "us-gaap_MinorityInterest",
              "unit": "usd",
              "label": "Minority Interest",
              "value": 2429000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsCurrent",
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 3651000000.0
            },
            {
              "concept": "us-gaap_OtherAssetsNoncurrent",
              "unit": "usd",
              "label": "Other Assets",
              "value": 5626000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentGross",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Gross",
              "value": 30563000000.0
            },
            {
              "concept": "us-gaap_PropertyPlantAndEquipmentNet",
              "unit": "usd",
              "label": "Property, Plant and Equipment, Net",
              "value": 17082000000.0
            },
            {
              "concept": "us-gaap_ReceivablesNetCurrent",
              "unit": "usd",
              "label": "Receivables, Net, Current",
              "value": 7344000000.0
            },
            {
              "concept": "us-gaap_RetainedEarningsAccumulatedDeficit",
              "unit": "usd",
              "label": "Retained Earnings (Accumulated Deficit)",
              "value": 37536000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquity",
              "unit": "usd",
              "label": "Stockholders Equity",
              "value": 54376000000.0
            },
            {
              "concept": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
              "value": 56805000000.0
            },
            {
              "concept": "us-gaap_TreasuryStockValue",
              "unit": "usd",
              "label": "Treasury Stock, Value",
              "value": 22433000000.0
            }
          ],
          "ic": [
            {
              "concept": "mrk_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests",
              "unit": "usd",
              "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interests",
              "value": 1653000000.0
            },
            {
              "concept": "mrk_TotalCostsExpensesAndOther",
              "unit": "usd",
              "label": "Total Costs Expenses And Other",
              "value": 44334000000.0
            },
            {
              "concept": "us-gaap_CostOfGoodsSold",
              "unit": "usd",
              "label": "Cost of Goods Sold",
              "value": 18396000000.0
            },
            {
              "concept": "us-gaap_EarningsPerShareBasic",
              "unit": "usdeps",
              "label": "Earnings Per Share, Basic",
              "value": 0.28
            },
            {
              "concept": "us-gaap_EarningsPerShareDiluted",
              "unit": "usdeps",
              "label": "Earnings Per Share, Diluted",
              "value": 0.28
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 587000000.0
            },
            {
              "concept": "us-gaap_IncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Income Tax Expense (Benefit)",
              "value": 671000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLoss",
              "unit": "usd",
              "label": "Net Income Loss",
              "value": 861000000.0
            },
            {
              "concept": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
              "unit": "usd",
              "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
              "value": 121000000.0
            },
            {
              "concept": "us-gaap_OtherNonoperatingIncomeExpense",
              "unit": "usd",
              "label": "Other Nonoperating Income (Expense)",
              "value": -1304000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 982000000.0
            },
            {
              "concept": "us-gaap_ResearchAndDevelopmentExpense",
              "unit": "usd",
              "label": "Research and Development Expense",
              "value": 10991000000.0
            },
            {
              "concept": "us-gaap_RestructuringCharges",
              "unit": "usd",
              "label": "Restructuring Charges",
              "value": 985000000.0
            },
            {
              "concept": "us-gaap_Revenues",
              "unit": "usd",
              "label": "Revenues",
              "value": 45987000000.0
            },
            {
              "concept": "us-gaap_SellingGeneralAndAdministrativeExpense",
              "unit": "usd",
              "label": "Selling, General and Administrative Expense",
              "value": 13245000000.0
            }
          ],
          "cf": [
            {
              "concept": "mrk_GainOnDistributionFromPartner",
              "unit": "usd",
              "label": "Gain On Distribution From Partner",
              "value": 443000000.0
            },
            {
              "concept": "mrk_IncreaseDecreaseInAccruedAndOtherCurrentLiabilities",
              "unit": "usd",
              "label": "Increase Decrease In Accrued And Other Current Liabilities",
              "value": 35000000.0
            },
            {
              "concept": "mrk_IncreaseDecreaseInRestrictedCashInvestments",
              "unit": "usd",
              "label": "Increase Decrease In Restricted Cash Investments",
              "value": 276000000.0
            },
            {
              "concept": "mrk_OtherDividendsPaid",
              "unit": "usd",
              "label": "Other Dividends Paid",
              "value": 119000000.0
            },
            {
              "concept": "mrk_PurchasesSecuritiesAndOtherInvestments",
              "unit": "usd",
              "label": "Purchases Securities And Other Investments",
              "value": 7197000000.0
            },
            {
              "concept": "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther",
              "unit": "usd",
              "label": "Other",
              "value": 377000000.0
            },
            {
              "concept": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
              "unit": "usd",
              "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
              "value": 1589000000.0
            },
            {
              "concept": "us-gaap_DeferredIncomeTaxExpenseBenefit",
              "unit": "usd",
              "label": "Total deferred provision",
              "value": -1092000000.0
            },
            {
              "concept": "us-gaap_DepreciationDepletionAndAmortization",
              "unit": "usd",
              "label": "Depreciation, Depletion and Amortization",
              "value": 7381000000.0
            },
            {
              "concept": "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents",
              "unit": "usd",
              "label": "Effect of Exchange Rate Changes on Cash and Cash Equivalents",
              "value": -295000000.0
            },
            {
              "concept": "us-gaap_EquityMethodInvestmentDividendsOrDistributions",
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 324000000.0
            },
            {
              "concept": "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
              "unit": "usd",
              "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
              "value": 2441000000.0
            },
            {
              "concept": "us-gaap_IncomeLossFromEquityMethodInvestments",
              "unit": "usd",
              "label": "Income (Loss) from Equity Method Investments",
              "value": 587000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsPayableTrade",
              "unit": "usd",
              "label": "Increase (Decrease) in Accounts Payable, Trade",
              "value": 124000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccountsReceivable",
              "unit": "usd",
              "label": "Increase (Decrease) in Accounts Receivable",
              "value": 1089000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable",
              "unit": "usd",
              "label": "Increase (Decrease) in Accrued Income Taxes Payable",
              "value": 128000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInInventories",
              "unit": "usd",
              "label": "Increase (Decrease) in Inventories",
              "value": -1990000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet",
              "unit": "usd",
              "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
              "value": 160000000.0
            },
            {
              "concept": "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities",
              "unit": "usd",
              "label": "Increase (Decrease) in Other Operating Liabilities",
              "value": -98000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by (Used in) Financing Activities",
              "value": -5441000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
              "unit": "usd",
              "label": "Net Cash (Used in) Provided by Investing Activities",
              "value": -3497000000.0
            },
            {
              "concept": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
              "unit": "usd",
              "label": "Net Cash Provided by Operating Activities",
              "value": 10822000000.0
            },
            {
              "concept": "us-gaap_PaymentsForProceedsFromOtherInvestingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -150000000.0
            },
            {
              "concept": "us-gaap_PaymentsForRepurchaseOfCommonStock",
              "unit": "usd",
              "label": "Payments for Repurchase of Common Stock",
              "value": 1593000000.0
            },
            {
              "concept": "us-gaap_PaymentsOfDividendsCommonStock",
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 4734000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
              "unit": "usd",
              "label": "Payments to Acquire Businesses, Net of Cash Acquired",
              "value": 256000000.0
            },
            {
              "concept": "us-gaap_PaymentsToAcquireProductiveAssets",
              "unit": "usd",
              "label": "Capital expenditures",
              "value": 1678000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromIssuanceOfLongTermDebt",
              "unit": "usd",
              "label": "Proceeds From Issuance Of Long Term Debt",
              "value": 1999000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities",
              "unit": "usd",
              "label": "Other",
              "value": -106000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
              "unit": "usd",
              "label": "Net change in short-term borrowings",
              "value": 90000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments",
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 4561000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments",
              "unit": "usd",
              "label": "Proceeds From Sale Of Equity Method Investments",
              "value": 647000000.0
            },
            {
              "concept": "us-gaap_ProceedsFromStockOptionsExercised",
              "unit": "usd",
              "label": "Proceeds from Stock Options Exercised",
              "value": 363000000.0
            },
            {
              "concept": "us-gaap_ProfitLoss",
              "unit": "usd",
              "label": "Net Income",
              "value": 982000000.0
            },
            {
              "concept": "us-gaap_RepaymentsOfLongTermDebt",
              "unit": "usd",
              "label": "Payments on debt",
              "value": 1341000000.0
            },
            {
              "concept": "us-gaap_ShareBasedCompensation",
              "unit": "usd",
              "label": "Share Based Compensation",
              "value": 509000000.0
            }
          ]
        }
      },
      {
        "accessNumber": "0000950123-10-030079",
        "symbol": "MRK",
        "cik": "64978",
        "year": 2009,
        "quarter": 0,
        "form": "10-K",
        "startDate": "2009-01-01 00:00:00",
        "endDate": "2009-12-31 00:00:00",
        "filedDate": "2010-03-30 00:00:00",
        "acceptedDate": "2010-03-30 16:48:21",
        "report": {
          "bs": [
            {
              "unit": "usd",
              "label": "",
              "value": 6632800000,
              "concept": "CashAndCashEquivalentsAtCarryingValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 293100000,
              "concept": "MarketableSecuritiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3280500000,
              "concept": "ReceivablesNetCurrent"
            },
            {
              "unit": "usd",
              "label": "Inventories (excludes inventories of $1,157.2 in 2009 and $587.3 in 2008 classified in Other assets - see Note 8)",
              "value": 2147700000,
              "concept": "InventoryNet"
            },
            {
              "unit": "usd",
              "label": "Deferred income taxes and other current assets",
              "value": 2100700000,
              "concept": "OtherAssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15487500000,
              "concept": "AssetsCurrent"
            },
            {
              "unit": "usd",
              "label": "Investments",
              "value": 430300000,
              "concept": "MarketableSecuritiesNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 325300000,
              "concept": "Land"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 9618900000,
              "concept": "BuildingsAndImprovementsGross"
            },
            {
              "unit": "usd",
              "label": "Machinery, equipment and office furnishings",
              "value": 13002900000,
              "concept": "mrk:MachineryEquipmentAndOfficeFurnishings"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1231700000,
              "concept": "ConstructionInProgressGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 24178800000,
              "concept": "PropertyPlantAndEquipmentGross"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 12526000000,
              "concept": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 11652800000,
              "concept": "PropertyPlantAndEquipmentNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1439000000,
              "concept": "Goodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 523200000,
              "concept": "IntangibleAssetsNetExcludingGoodwill"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5149400000,
              "concept": "OtherAssetsNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 41749700000,
              "concept": "Assets"
            },
            {
              "unit": "usd",
              "label": "Loans payable and current portion of long-term debt",
              "value": 450500000,
              "concept": "DebtCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 646800000,
              "concept": "AccountsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": 5477300000,
              "concept": "mrk:AccruedAndOtherCurrentLiabilities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 583700000,
              "concept": "AccruedIncomeTaxesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 0,
              "concept": "DividendsPayableCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8017800000,
              "concept": "LiabilitiesCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8067800000,
              "concept": "LongTermDebtNoncurrent"
            },
            {
              "unit": "usd",
              "label": "Deferred Income Taxes and Noncurrent Liabilities",
              "value": 7382400000,
              "concept": "mrk:DeferredTaxesAndNoncurrentLiabilities"
            },
            {
              "unit": "usd",
              "label": "Retained earnings",
              "value": 37641800000,
              "concept": "RetainedEarningsAccumulatedDeficit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -2565600000,
              "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax"
            },
            {
              "unit": "usd",
              "label": "Stockholders' equity before deduction for treasury stock",
              "value": 43759400000,
              "concept": "mrk:StockholdersEquityBeforeDeductionForTreasuryStock"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 0,
              "concept": "TreasuryStockValue"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 15869500000,
              "concept": "StockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2412200000,
              "concept": "MinorityInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 18281700000,
              "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 41749700000,
              "concept": "LiabilitiesAndStockholdersEquity"
            },
            {
              "unit": "usd",
              "label": "Investment in MSD's Parent Company",
              "value": 19080200000,
              "concept": "mrk:InvestmentInParentCompany"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1032700000,
              "concept": "DueFromAffiliateCurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7067500000,
              "concept": "DueFromAffiliateNoncurrent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 859500000,
              "concept": "DueToAffiliateCurrent"
            },
            {
              "unit": "usd",
              "label": "Receivables from MSD's Parent Company",
              "value": 8809700000,
              "concept": "mrk:AmountReceivablesFromParentCompany"
            },
            {
              "unit": "usd",
              "label": "Contributed capital",
              "value": 8683200000,
              "concept": "mrk:CapitalContributed"
            }
          ],
          "cf": [
            {
              "unit": "usd",
              "label": "",
              "value": 8075100000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "Gain on disposition of interest in Merial Limited",
              "value": -3162500000,
              "concept": "mrk:GainLossOnSaleOfEquityMethodInvestment"
            },
            {
              "unit": "usd",
              "label": "Equity income from affiliates",
              "value": 2503000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "Dividends and distributions from equity affiliates",
              "value": 2030900000,
              "concept": "EquityMethodInvestmentDividendsOrDistributions"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1662200000,
              "concept": "DepreciationDepletionAndAmortization"
            },
            {
              "unit": "usd",
              "label": "Deferred income taxes",
              "value": 2168500000,
              "concept": "DeferredIncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 376000000,
              "concept": "ShareBasedCompensation"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -514800000,
              "concept": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -372800000,
              "concept": "IncreaseDecreaseInAccountsReceivable"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -195500000,
              "concept": "IncreaseDecreaseInInventories"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 23700000,
              "concept": "IncreaseDecreaseInAccountsPayableTrade"
            },
            {
              "unit": "usd",
              "label": "Accrued and other current liabilities",
              "value": -3981600000,
              "concept": "mrk:IncreaseDecreaseInAccruedAndOtherCurrentLiabilities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -128900000,
              "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -155900000,
              "concept": "IncreaseDecreaseInOtherOperatingLiabilities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 63400000,
              "concept": "IncreaseDecreaseInOtherOperatingCapitalNet"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3384800000,
              "concept": "NetCashProvidedByUsedInOperatingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 1294300000,
              "concept": "PaymentsToAcquireProductiveAssets"
            },
            {
              "unit": "usd",
              "label": "Purchases of securities and other investments",
              "value": 3070800000,
              "concept": "mrk:PurchasesSecuritiesAndOtherInvestments"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sales of securities and other investments",
              "value": 10713800000,
              "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments"
            },
            {
              "unit": "usd",
              "label": "Proceeds from sale of interest in Merial Limited",
              "value": 4000000000,
              "concept": "mrk:ProceedsFromSaleOfEquityMethodInvestment"
            },
            {
              "unit": "usd",
              "label": "Acquisitions of subsidiaries, net of cash acquired",
              "value": 130000000,
              "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired"
            },
            {
              "unit": "usd",
              "label": "Decrease (increase) in restricted assets",
              "value": 5474300000,
              "concept": "mrk:IncreaseDecreaseInRestrictedCashInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -33800000,
              "concept": "PaymentsForProceedsFromOtherInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7937000000,
              "concept": "NetCashProvidedByUsedInInvestingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -1094900000,
              "concept": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 4228000000,
              "concept": "ProceedsFromIssuanceOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 25300000,
              "concept": "RepaymentsOfLongTermDebt"
            },
            {
              "unit": "usd",
              "label": "Dividends paid to stockholders",
              "value": 3215000000,
              "concept": "PaymentsOfDividendsCommonStock"
            },
            {
              "unit": "usd",
              "label": "Proceeds from exercise of stock options",
              "value": 38500000,
              "concept": "ProceedsFromStockOptionsExercised"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -124300000,
              "concept": "ProceedsFromPaymentsForOtherFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -9122700000,
              "concept": "NetCashProvidedByUsedInFinancingActivities"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 65400000,
              "concept": "EffectOfExchangeRateOnCashAndCashEquivalents"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2264500000,
              "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease"
            },
            {
              "unit": "usd",
              "label": "Other dividends paid",
              "value": 120000000,
              "concept": "mrk:OtherDividendsPaid"
            },
            {
              "unit": "usd",
              "label": "",
              "value": -8809700000,
              "concept": "ProceedsFromContributionsFromParent"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7789800000,
              "concept": "PaymentsForAdvanceToAffiliate"
            }
          ],
          "ic": [
            {
              "unit": "usd",
              "label": "",
              "value": 23643200000,
              "concept": "Revenues"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5590800000,
              "concept": "CostOfGoodsSold"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7323800000,
              "concept": "SellingGeneralAndAdministrativeExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 5139200000,
              "concept": "ResearchAndDevelopmentExpense"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 545600000,
              "concept": "RestructuringCharges"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2503000000,
              "concept": "IncomeLossFromEquityMethodInvestments"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 3275800000,
              "concept": "OtherNonoperatingIncomeExpense"
            },
            {
              "unit": "usd",
              "label": "Total Costs, Expenses and Other",
              "value": 12820600000,
              "concept": "mrk:TotalCostsExpensesAndOther"
            },
            {
              "unit": "usd",
              "label": "Income Before Taxes",
              "value": 10822600000,
              "concept": "mrk:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterests"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 2747500000,
              "concept": "IncomeTaxExpenseBenefit"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 8075100000,
              "concept": "ProfitLoss"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 122800000,
              "concept": "NetIncomeLossAttributableToNoncontrollingInterest"
            },
            {
              "unit": "usd",
              "label": "",
              "value": 7952300000,
              "concept": "NetIncomeLoss"
            }
          ]
        }
      }
    ],
    "symbol": "MRK"
  }
}